C88.40 Billable / specific Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission

ICD-10-CM C88.40 identifies “Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 2: Neoplasms

Code-level instructions

Inclusion terms8
  • Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] NOS
  • Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] with failed remission
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] NOS
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] not having achieved remission
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] with failed remission
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] NOS
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] not having achieved remission
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] with failed remission

Inherited instructions

Chapters 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C88 · Malignant immunoproliferative diseases and certain other B-cell lymphomas

Excludes 12
  • B-cell lymphoma, unspecified (C85.1-)
  • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)

C88.4 · Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]

Inclusion terms2
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma]
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma]
Excludes 11

high malignant (diffuse large B-cell) lymphoma (C83.3-)

Official index references

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2024-10-01

Previous assignment: C88.4

History

Code history

Latest recorded change · FY2025

ChangedUnchanged
FY2025

Effective from

  • Added

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission

Billable diagnosis code

CDC/NCHS · FY2025

All editions (5)

All editionsEffective fromCode history
FY20252024-10-01Added
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.